Skip to main content

Find Clinical Trials

Home
Conditions
RB1-Negative

Clinical trial condition

RB1-Negative

Explore clinical trials studying RB1-Negative. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

RB1-Negative trial results

Recruiting

A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy

NCT07633756

Conditions: Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +7 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details